⏳ Fetching live dividend data...
Home › Calculator › MLLCF Dividend Calculator 2026
Molecular Partners AG · OTC
Price: $2.55 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in MLLCF → $90517280118.93M in 10 years · $7,533,726,304,470,152.00/month
Molecular Partners AG operates as a clinical-stage biopharmaceutical firm dedicated to the discovery, advancement, and commercialization of therapeutic protein treatments. Its portfolio of investigational products, primarily based on DARPin technology, features Abicipar, which is undergoing Phase III clinical trials for the management of neovascular wet age-related macular degeneration and diabetic macular edema. Another significant candidate is MP0420, a multi-specific DARPin designed to combat the SARS-CoV-2 virus. The company's pipeline further includes MP0310, in Phase Ia for immuno-oncology applications; MP0317, a tumor-localized immune agonist that stimulates immune cells within tumors, currently in Phase I; and MP0274, also in Phase I for HER2-positive cancers. Additional developments include MP0423 for treating COVID-19; MP0533, a CD3 T cell-targeting agent for acute myeloid leukemia; and MP0250, engineered to interact with vascular endothelial growth factor, hepatocyte growth factor, and human serum albumin to prolong its half-life. Molecular Partners AG maintains collaborations with major pharmaceutical companies such as Novartis AG (for the development, manufacturing, and commercialization of DARPin-conjugated radioligand therapies), Amgen SA, and Allergan, Inc., alongside a discovery alliance in ophthalmology with AbbVie Inc., and other third-party partners. The company, established in 2004, is headquartered in Schlieren, Switzerland.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open MLLCF position with:
Real after-tax yield depends on where you live and how you hold MLLCF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 78.43% | 75.63% | $7,843 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 66.67% | 63.87% | $6,667 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 62.74% | 59.94% | $6,274 / yr |
| 🇬🇧 UK ISA | 0% | 78.43% | 75.63% | $7,843 / yr |
| 🇬🇧 UK Taxable | 8.75% | 71.57% | 68.77% | $7,157 / yr |
| 🇨🇦 TFSA | 0% | 78.43% | 75.63% | $7,843 / yr |
| 🇨🇦 CA Taxable | 25% | 58.82% | 56.02% | $5,882 / yr |
| 🇦🇺 Super (pension) | 15% | 66.67% | 63.87% | $6,667 / yr |
| 🇦🇺 AU Taxable | 30% | 54.90% | 52.10% | $5,490 / yr |
| 🇩🇪 DE Taxable | 26.375% | 57.74% | 54.94% | $5,774 / yr |
| 🇫🇷 FR Taxable | 30% | 54.90% | 52.10% | $5,490 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
MLLCF pays quarterly — 4 times per year. Next ex-div: TBD.
How MLLCF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for MLLCF sourced from FMP /financial-growth endpoint — real data, not estimates.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the MLLCF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →